Prediction of multiple pH compartments by deep learning in magnetic resonance spectroscopy with hyperpolarized 13C-labelled zymonic acid

被引:1
|
作者
Fok, Wai-Yan Ryana [1 ]
Grashei, Martin [2 ]
Skinner, Jason G. [2 ]
Menze, Bjoern H. [1 ]
Schilling, Franz [2 ,3 ]
机构
[1] Tech Univ Munich, Dept Informat, D-85748 Garching, Germany
[2] Tech Univ Munich, TUM Sch Med, Dept Nucl Med, Klinikum Rechts Isar, D-81675 Munich, Germany
[3] Tech Univ Munich, Munich Inst Biomed Engn, D-85748 Garching, Germany
关键词
Deep learning; Convolutional neural network; pH; Hyperpolarized 13C MRSI; MRI; CONTRAST;
D O I
10.1186/s13550-022-00894-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Hyperpolarization enhances the sensitivity of nuclear magnetic resonance experiments by between four and five orders of magnitude. Several hyperpolarized sensor molecules have been introduced that enable high sensitivity detection of metabolism and physiological parameters. However, hyperpolarized magnetic resonance spectroscopy imaging (MRSI) often suffers from poor signal-to-noise ratio and spectral analysis is complicated by peak overlap. Here, we study measurements of extracellular pH (pH(e)) by hyperpolarized zymonic acid, where multiple pH(e) compartments, such as those observed in healthy kidney or other heterogeneous tissue, result in a cluster of spectrally overlapping peaks, which is hard to resolve with conventional spectroscopy analysis routines. Methods We investigate whether deep learning methods can yield improved pH(e) prediction in hyperpolarized zymonic acid spectra of multiple pH(e) compartments compared to conventional line fitting. As hyperpolarized C-13-MRSI data sets are often small, a convolutional neural network (CNN) and a multilayer perceptron (MLP) were trained with either a synthetic or a mixed (synthetic and augmented) data set of acquisitions from the kidneys of healthy mice. Results Comparing the networks' performances compartment-wise on a synthetic test data set and eight real kidney data shows superior performance of CNN compared to MLP and equal or superior performance compared to conventional line fitting. For correct prediction of real kidney pH(e) values, training with a mixed data set containing only 0.5% real data shows a large improvement compared to training with synthetic data only. Using a manual segmentation approach, pH maps of kidney compartments can be improved by neural network predictions for voxels including three pH compartments. Conclusion The results of this study indicate that CNNs offer a reliable, accurate, fast and non-interactive method for analysis of hyperpolarized C-13 MRS and MRSI data, where low amounts of acquired data can be complemented to achieve suitable network training.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Detection of Transgene Expression Using Hyperpolarized 13C Urea and Diffusion-Weighted Magnetic Resonance Spectroscopy
    Patrick, P. Stephen
    Kettunen, Mikko I.
    Tee, Sui-Seng
    Rodrigues, Tiago B.
    Serrao, Eva
    Timm, Kerstin N.
    McGuire, Sarah
    Brindle, Kevin M.
    MAGNETIC RESONANCE IN MEDICINE, 2015, 73 (04) : 1401 - 1406
  • [42] Early In Vivo Detection of Radiation-Induced Cardiotoxicity With Hyperpolarized C-13 Pyruvate Magnetic Resonance Spectroscopy
    Zhang-Velten, E. R.
    Sharma, J.
    Wang, X.
    Ma, J.
    Chen, J.
    Schiattarella, G.
    Gillette, T.
    Hill, J.
    Park, J.
    Malloy, C.
    Zaha, V.
    Alluri, P. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S129 - S130
  • [43] Detection of radiation-induced lung injury using hyperpolarized 13C magnetic resonance spectroscopy and imaging
    Thind, K.
    Chen, A.
    Friesen-Waldner, L.
    Ouriadov, A.
    Scholl, T. J.
    Fox, M.
    Wong, E.
    VanDyk, J.
    Hope, A.
    Santyr, G.
    MAGNETIC RESONANCE IN MEDICINE, 2013, 70 (03) : 601 - 609
  • [44] The potential of hyperpolarized 13-C magnetic resonance spectroscopy to monitor the effect of combretastatin based vascular disrupting agents
    Iversen, Ane B.
    Busk, Morten
    Bertelsen, Lotte B.
    Laustsen, Christoffer
    Munk, Ole L.
    Nielsen, Thomas
    Wittenborn, Thomas R.
    Bussink, Johan
    Lok, Jasper
    Stodkilde-Jorgensen, Hans
    Horsman, Michael R.
    CANCER RESEARCH, 2017, 77
  • [45] Using Hyperpolarized 13C Magnetic Resonance Spectroscopy to Detect Radiation Induced Lung Injury at an Early Stage
    Thind, K.
    Ouriadov, A.
    Feiesen-Waldner, L.
    Chen, A.
    Scholl, T.
    Fox, M.
    Wong, E.
    VanDyk, J.
    Hill, R.
    Hope, A.
    Santyr, G.
    MEDICAL PHYSICS, 2011, 38 (06) : 3742 - +
  • [46] Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy (vol 13, pg 1382, 2007)
    Day, Sam E.
    Kettunen, Mikko I.
    Gallagher, Ferdia A.
    Hu, De-En
    Lerche, Mathilde
    Wolber, Jan
    Golman, Klaes
    Ardenkjaer-Larsen, Jan Henrik
    Brindle, Kevin M.
    NATURE MEDICINE, 2007, 13 (12) : 1521 - 1521
  • [47] C-13 MAGNETIC-RESONANCE SPECTROSCOPY OF SALICYLIC-ACID AND DERIVATIVES
    HASSAN, MMA
    ZUBAIR, MU
    SPECTROSCOPY LETTERS, 1982, 15 (07) : 533 - 542
  • [48] In Vivo Measurement of Ethanol Metabolism in the Rat Liver Using Magnetic Resonance Spectroscopy of Hyperpolarized [1-13C]Pyruvate
    Spielman, Daniel M.
    Mayer, Dirk
    Yen, Yi-Fen
    Tropp, James
    Hurd, Ralph E.
    Pfefferbaum, Adolf
    MAGNETIC RESONANCE IN MEDICINE, 2009, 62 (02) : 307 - 313
  • [49] Evidence for Rapid Oxidative Phosphorylation and Lactate Fermentation in Motile Human Sperm by Hyperpolarized 13C Magnetic Resonance Spectroscopy
    Steven Reynolds
    Nurul Fadhlina bt Ismail
    Sarah J. Calvert
    Allan A. Pacey
    Martyn N. J. Paley
    Scientific Reports, 7
  • [50] Monitoring response to a clinically relevant IDH inhibitor in glioma-Hyperpolarized 13C magnetic resonance spectroscopy approaches
    Hong, Donghyun
    Kim, Yaewon
    Mushti, Chandrasekhar
    Minami, Noriaki
    Wu, Jing
    Cherukuri, Murali Krishna
    Swenson, Rolf E.
    Vigneron, Daniel B.
    Ronen, Sabrina M.
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)